CURI vs OM
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
CURI
OM
Investment Advisor Scores
OM
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CURI | OM | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 8.0645 | 0 | Tie |
| PEG Ratio | 0 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 22.3% | 0.7% | CURI |
| Earnings Growth | 1400.0% | 0.0% | CURI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 35.2/100 | 46.3/100 | OM |
| Profit Margin | 0.0% | -63.1% | CURI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | AVOID NEW MONEY | HOLD | OM |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CURI
MarkdownPrice below a falling SMA50 (slope -3.0%), weak momentum, RSI 35
OM
NeutralMixed signals - no dominant trend phase, RSI 54
Fundamentals Snapshot
| Metric | CURI | OM |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 7.8 | -1.8 |
| Trailing P/E | — | — |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.2% | 0.0% |
| Gross Margin | 0.6% | 0.4% |
| Operating Margin | 0.4% | -0.5% |
| EPS | 0.00 | -3.78 |
| Dividend Yield | 0.13% | — |